Corbus Pharmaceuticals
CRBP
24 hedge funds and large institutions have $30.6M invested in Corbus Pharmaceuticals in 2016 Q2 according to their latest regulatory filings, with 8 funds opening new positions, 10 increasing their positions, 2 reducing their positions, and 6 closing their positions.
400% more repeat investments, than reductions
Existing positions increased: 10 | Existing positions reduced: 2
232% more capital invested
Capital invested by funds: $9.21M → $30.6M (+$21.4M)
33% more first-time investments, than exits
New positions opened: 8 | Existing positions closed: 6
9% more funds holding
Funds holding: 22 → 24 (+2)
0% more funds holding in top 10
Funds holding in top 10: 1 → 1 (0)
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
CAM
Cormorant Asset Management
Boston,
Massachusetts
|
+$5.23M |
| 2 |
PA
Perceptive Advisors
New York
|
+$5.1M |
| 3 |
DCM
DAFNA Capital Management
Los Angeles,
California
|
+$1.05M |
| 4 |
GTC
Ghost Tree Capital
New York
|
+$784K |
| 5 |
Vanguard Group
Malvern,
Pennsylvania
|
+$443K |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
RJA
Raymond James & Associates
St Petersburg,
Florida
|
-$153K |
| 2 |
LPL Financial
San Diego,
California
|
-$27K |
| 3 |
RJFSA
Raymond James Financial Services Advisors
St. Petersburg,
Florida
|
-$26.3K |
| 4 |
FAM
Formidable Asset Management
Cincinnati,
Ohio
|
-$22K |
| 5 |
IA
IFP Advisors
Tampa,
Florida
|
-$4K |
| Name | Holding | Trade Value |
Shares Change |
Change in Stake |
|
|---|---|---|---|---|---|
|
26
LPL Financial
San Diego,
California
| – | -$27K | -467 | Closed |
|
|
FAM
27
Formidable Asset Management
Cincinnati,
Ohio
| – | -$22K | -333 | Closed |
|
28
Bank of Montreal
Toronto,
Ontario, Canada
| – | -$2K | -33 | Closed |
|
|
IA
29
IFP Advisors
Tampa,
Florida
| – | -$4K | -19 | Closed |
|
|
TRCT
30
Tower Research Capital (TRC)
New York
| – | -$1K | -16 | Closed |
|
CRBP Hedge Fund Activity: Q2 2016 in Review
24 of the 3,748 institutional investors tracked by Wall St. Rank reported a position in Corbus Pharmaceuticals (CRBP) for Q2 2016, worth a combined $30.6M — up 232% from $9.21M a quarter earlier.
Buyers outnumbered sellers: 8 funds opened new CRBP positions and 6 closed out — a net gain of 2 holders — while 10 added to existing stakes and 2 trimmed.
The largest buyer was Cormorant Asset Management, opening a new position worth an estimated $5.23M. The largest seller was Raymond James & Associates, exiting entirely with an estimated $153K sold.
- 24 institutional investors held Corbus Pharmaceuticals (CRBP) as of Q2 2016, up from 22 in Q1 2016.
- Funds reported $30.6M of Corbus Pharmaceuticals stock for Q2 2016, up 232% quarter-over-quarter.
- 8 funds opened new Corbus Pharmaceuticals positions in Q2 2016 and 6 closed out, a net change of +2 holders.
- The largest Corbus Pharmaceuticals buyer in Q2 2016 was Cormorant Asset Management, an estimated $5.23M added.
- The largest Corbus Pharmaceuticals seller in Q2 2016 was Raymond James & Associates, an estimated $153K sold.
Based on aggregated 13F filings for Q2 2016.